• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中浆经半剂量光动力疗法治疗后脉络膜毛细血管层、Sattler 层和 Haller 层厚度的变化。

CHANGES IN CHORIOCAPILLARIS, SATTLER, AND HALLER LAYER THICKNESSES IN CENTRAL SEROUS CHORIORETINOPATHY AFTER HALF-FLUENCE PHOTODYNAMIC THERAPY.

机构信息

Puerta de Hierro University Hospital, Majadahonda, Madrid, Spain.

Clínico San Carlos University Hospital, Madrid, Spain.

出版信息

Retina. 2020 Dec;40(12):2373-2378. doi: 10.1097/IAE.0000000000002764.

DOI:10.1097/IAE.0000000000002764
PMID:31985718
Abstract

PURPOSE

To determinate the variation in thickness of the individual choroidal layers in patients with central serous chorioretinopathy treated with half-fluence photodynamic therapy.

METHODS

Twenty-two eyes were evaluated with spectral-domain optical coherence tomography. The images were taken before photodynamic therapy, 3 months, and 6 months after the treatment. Two investigators performed these measurements: 1) choroidal thickness (CT), 2) Haller layer thickness, defined as the most external layer containing a 100-μm vessel, and 3) choriocapillaris + Sattler layer (C&S). Nine measurements were taken in the macular region.

RESULTS

Choroidal thickness before photodynamic therapy was 471.8 µm ± 145.8. The Haller layer was 358.4 µm ± 122.6, and C&S was 114.3 µm ± 27.8. At 3-month follow-up, CT was 441.1 µm ± 150.7, Haller layer 348.8 µm ± 127.6, and C&S 92.4 µm ± 27.9. At 6-month follow-up, CT was 420.4 µm ± 118.4, Haller layer 331.8 µm ± 97.2, and C&S 89.5 µm ± 28.0. Using a multilevel mixed-effects linear regression, CT was found to be reduced at both 3 months (P < 0.03) and at 6 months (P < 0.001), Haller layer showed no significant reduction at 3 months (P = 0.483) or at 6 months (P = 0.055), and C&S showed reduction at 3 months (P < 0.001) and at 6 months (P < 0.001). Fellow nonaffected eyes showed no statistical variation at 3-month and 6-month follow-up.

CONCLUSION

Reduction in CT in patients affected by central serous chorioretinopathy after half-fluence photodynamic therapy occurs primarily in the choriocapillaris and medium diameter vessel layers of the choroid in a short- and medium-term follow-up.

摘要

目的

确定接受半剂量光动力疗法治疗的中心性浆液性脉络膜视网膜病变患者各脉络膜层厚度的变化。

方法

使用频域光相干断层扫描对 22 只眼进行评估。在光动力疗法前、治疗后 3 个月和 6 个月采集图像。两名研究人员进行了以下测量:1)脉络膜厚度(CT),2)Haller 层厚度,定义为含有 100μm 血管的最外层,3)脉络膜毛细血管+Sattler 层(C&S)。在黄斑区进行了 9 次测量。

结果

光动力疗法前 CT 为 471.8μm±145.8。Haller 层为 358.4μm±122.6,C&S 为 114.3μm±27.8。在 3 个月随访时,CT 为 441.1μm±150.7,Haller 层为 348.8μm±127.6,C&S 为 92.4μm±27.9。在 6 个月随访时,CT 为 420.4μm±118.4,Haller 层为 331.8μm±97.2,C&S 为 89.5μm±28.0。使用多级混合效应线性回归,发现 CT 在 3 个月(P<0.03)和 6 个月(P<0.001)时均减少,Haller 层在 3 个月(P=0.483)和 6 个月(P=0.055)时均无明显减少,C&S 在 3 个月(P<0.001)和 6 个月(P<0.001)时减少。对侧非受影响眼在 3 个月和 6 个月随访时均无统计学差异。

结论

在接受半剂量光动力疗法治疗的中心性浆液性脉络膜视网膜病变患者中,CT 在短期和中期随访中主要减少,发生在脉络膜的脉络膜毛细血管和中等直径血管层。

相似文献

1
CHANGES IN CHORIOCAPILLARIS, SATTLER, AND HALLER LAYER THICKNESSES IN CENTRAL SEROUS CHORIORETINOPATHY AFTER HALF-FLUENCE PHOTODYNAMIC THERAPY.中浆经半剂量光动力疗法治疗后脉络膜毛细血管层、Sattler 层和 Haller 层厚度的变化。
Retina. 2020 Dec;40(12):2373-2378. doi: 10.1097/IAE.0000000000002764.
2
Optical coherent tomographic angiographic pattern of the deep choroidal layer and choriocapillaris after photodynamic therapy for central serous chorioretinopathy.中心性浆液性脉络膜视网膜病变光动力治疗后深层脉络膜层和脉络膜毛细血管的光学相干断层扫描血管造影模式
Graefes Arch Clin Exp Ophthalmol. 2019 Jul;257(7):1365-1372. doi: 10.1007/s00417-019-04318-x. Epub 2019 Apr 29.
3
CHOROIDAL THICKNESS IN PATIENTS WITH CENTRAL SEROUS CHORIORETINOPATHY: Assessment of Haller and Sattler Layers.中心性浆液性脉络膜视网膜病变患者的脉络膜厚度:对哈勒层和萨特勒层的评估
Retina. 2016 Sep;36(9):1652-7. doi: 10.1097/IAE.0000000000000998.
4
One-year choroidal thickness results after photodynamic therapy for central serous chorioretinopathy.中心性浆液性脉络膜视网膜病变光动力治疗后 1 年的脉络膜厚度结果。
Retina. 2011 Oct;31(9):1921-7. doi: 10.1097/IAE.0b013e31822bf6b1.
5
Half-fluence photodynamic therapy in chronic central serous chorioretinopathy.半剂量光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变。
Retina. 2013 Feb;33(2):316-23. doi: 10.1097/IAE.0b013e318280769c.
6
Half-fluence photodynamic therapy in acute central serous chorioretinopathy.急性中心性浆液性脉络膜视网膜病变的半剂量光动力疗法。
Retina. 2012 Nov-Dec;32(10):2014-9. doi: 10.1097/IAE.0b013e318242b9ab.
7
Comparison of Focal and Conventional Verteporfin Photodynamic Therapy for Chronic Central Serous Chorioretinopathy.聚焦式与传统维替泊芬光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变的比较
Korean J Ophthalmol. 2019 Dec;33(6):506-513. doi: 10.3341/kjo.2019.0065.
8
Quantitative evaluation of choriocapillaris using optical coherence tomography and optical coherence tomography angiography in patients with central serous chorioretinopathy after half-dose photodynamic therapy.半剂量光动力疗法治疗中心性浆液性脉络膜视网膜病变后应用光相干断层扫描和光相干断层扫描血管成像定量评估脉络膜毛细血管。
PLoS One. 2020 Jan 13;15(1):e0227718. doi: 10.1371/journal.pone.0227718. eCollection 2020.
9
Vascular and structural alterations of the choroid evaluated by optical coherence tomography angiography and optical coherence tomography after half-fluence photodynamic therapy in chronic central serous chorioretinopathy.在慢性中心性浆液性脉络膜视网膜病变中,通过光学相干断层扫描血管造影和光学相干断层扫描评估半量光动力治疗后脉络膜的血管和结构改变。
Graefes Arch Clin Exp Ophthalmol. 2019 May;257(5):905-912. doi: 10.1007/s00417-018-04226-6. Epub 2019 Jan 7.
10
Microperimetric changes and fixation stability status after half-dose photodynamic therapy for chronic central serous chorioretinopathy.慢性中心性浆液性脉络膜视网膜病变半剂量光动力治疗后的微视野变化及固视稳定性状态
Eur J Ophthalmol. 2020 Sep;30(5):1053-1060. doi: 10.1177/1120672119858877. Epub 2019 Jul 1.

引用本文的文献

1
Crossover to PDT after the unsuccessful micropulse laser treatment of central serous chorioretinopathy.中心性浆液性脉络膜视网膜病变微脉冲激光治疗失败后交叉接受光动力疗法。
Adv Ophthalmol Pract Res. 2024 Jan 23;4(1):32-38. doi: 10.1016/j.aopr.2024.01.004. eCollection 2024 Feb-Mar.
2
Effect of photodynamic therapy on choroid of the medial area from optic disc in patients with central serous chorioretinopathy.光动力疗法对中心性浆液性脉络膜视网膜病变患者视盘内侧脉络膜的影响。
PLoS One. 2023 Feb 21;18(2):e0282057. doi: 10.1371/journal.pone.0282057. eCollection 2023.
3
Effectiveness, Safety and Choroidal Changes of a Fovea-Sparing Technique for the Treatment of Chronic Central Serous Chorioretinopathy with Yellow Subthreshold Laser.
黄斑中心凹保留技术联合黄色阈下激光治疗慢性中心性浆液性脉络膜视网膜病变的有效性、安全性及脉络膜变化
J Clin Med. 2023 Jan 31;12(3):1127. doi: 10.3390/jcm12031127.